Novo Nordisk's pricing techniques within the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of price gouging, pointing out the stark distinction among U.S. costs and those in Europe and copyright.This led Novo Nordisk to carry out further investigation into bigger dosages of semaglutide specificall